PRIMED Medical Products will establish its new major medical manufacturing facility in Cambridge, Ontario, Canada.
PRIMED said operations in Cambridge will commence in the Fall of 2020 and an additional 40-50 jobs will be created during the initial launch phase of this major expansion. This facility will produce both ASTM-rated surgical masks and N95 respirators in a phased scale-up process to support Canada’s healthcare systems.
“We are thrilled to be bringing mask manufacturing to our home country with this state-of-the-art plant in Cambridge,” said David Welsh, CEO of PRIMED. “After a comprehensive nation-wide search Ontario proved to be the ideal location, providing us with great access to the talent we need to set-up and run this facility.”
“We can’t wait to get our new operation started,” stated Welsh. “We are continuing to do our part to make sure Canadians have a long term, reliable solution to ensure the security of clinically preferred PPE supply domestically.”
According to company officials this production facility will have sufficient capacity to produce all of Canadian acute care’s normal surgical mask requirements with the ability to surge production significantly during pandemic or emergency events. PRIMED said it views this expansion as an important contribution to solidify Canada’s medical personal protective equipment supply chain.
“With convenient access to Toronto’s Pearson International Airport, Hamilton’s John C. Munro International Airport, as well as the Region of Waterloo International Airport, Cambridge is well connected to many international goods and travel options,” officials added.
The community of Cambridge and the region of Waterloo have both been strongly supportive of PRIMED’s investment in their area.
“Cambridge is known throughout the province for our advanced manufacturing sector. With our focus on innovation, our strong work force and enviable amenities, we are the ideal location for PRIMED’s newest facility,” said Cambridge Mayor Kathryn McGarry.
“The addition of PRIMED to Cambridge’s business landscape will strengthen our medical innovation sector and encourage future growth,” James Goodram, Director of Economic Development, City of Cambridge noted.